# OnCo record paper-cll12-ibrutinib-early-stage-langerbeins-jco-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cll12-ibrutinib-early-stage-langerbeins-jco-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cll12-ibrutinib-early-stage-langerbeins-jco-2025" ;
  schema:name "CLL12: ibrutinib in early-stage chronic lymphocytic leukaemia, a randomised placebo-controlled phase 3 trial"@en ;
  schema:description "Giving the pill ibrutinib to people with early, symptom-free chronic lymphocytic leukaemia delayed the disease but, after almost six years, did not help them live longer than placebo, so doctors should keep watching and waiting rather than treating early."@en ;
  schema:url <https://onco.cc/key-papers/paper-cll12-ibrutinib-early-stage-langerbeins-jco-2025/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.24.00975>, <https://pubmed.ncbi.nlm.nih.gov/39602678/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.24.00975> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Langerbeins P, Robrecht S, Nieper P, et al." ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/cll-treatment-naive/> ;
  onco:drugs <https://onco.cc/drugs/ibrutinib/> ;
  onco:trials <https://onco.cc/trials/cll12/> ;
  onco:journals <https://onco.cc/journals/jco/> .
